Market Place
Sourcing Support
Hubble Therapeutics Selects Andelyn to Manufacture Clinical Grade AAV
10 Oct 2024 //
CONTRACT PHARMA
Andelyn Biosciences, UMass Partner on Cockayne Syndrome
18 Jul 2024 //
CONTRACT PHARMA
UMass Chan receives $2.2 million to fund gene therapy for Cockayne syndrome
11 Jun 2024 //
PRESS RELEASE
Andelyn Biosciences selects viral vector manufacturing partner for CIRM
27 May 2024 //
PHARMABIZ
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the CIRM
23 May 2024 //
PRESS RELEASE
Andelyn Biosciences & Grace Science Partner to Tech Transfer Phase I/II/III Mfg
25 Mar 2024 //
PRESS RELEASE
Andelyn Biosciences Partners with Grace Science to Advance GS-100
25 Mar 2024 //
PR NEWSWIRE
Andelyn Biosciences and Armatus Bio Partner to Manufacture AAV Gene Therapy
15 Jan 2024 //
PR NEWSWIRE
Andelyn Selected by Ultragenyx for PPQ Manufacturing for Sanfilippo Syndrome
18 Dec 2023 //
PR NEWSWIRE
Andelyn Biosciences Opens New CGT Manufacturing HQ
22 Jun 2023 //
CONTRACT PHARMA
Cell and Gene Therapy CDMO Andelyn Biosciences Celebrates Over 20 Year
22 Jun 2023 //
BUSINESSWIRE
Andelyn debuts cell and gene manufacturing facility in Ohio
22 Jun 2023 //
FIERCE PHARMA
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract
08 Feb 2023 //
CONTRACT PHARMA
3 Ohio-based contract organizations win $149M deal for neurological candidates
12 Jan 2023 //
ENDPTS
Andelyn to Bring First Gene Therapy for Treatment of INAD to Clinical Trials
29 Nov 2022 //
CONTRACTPHARMA
Trends In AAV Development and Manufacturing for Gene Therapies
28 Nov 2022 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.